litlas
Log inCreate account

Shibo Jiang

Active 1993–2025

240
Papers
37,296
Citations
105
h-index
233
i10-index

Citations

Citations per year for Shibo Jiang1974: 1 citations1978: 3 citations1979: 1 citations1982: 1 citations1987: 1 citations1988: 1 citations1991: 2 citations1994: 1 citations1995: 9 citations1996: 2 citations1997: 8 citations1998: 8 citations1999: 12 citations2000: 19 citations2001: 13 citations2002: 23 citations2003: 15 citations2004: 51 citations2005: 88 citations2006: 103 citations2007: 97 citations2008: 111 citations2009: 125 citations2010: 117 citations2011: 60 citations2012: 78 citations2013: 119 citations2014: 166 citations2015: 180 citations2016: 245 citations2017: 140 citations2018: 149 citations2019: 595 citations2020: 4,967 citations2021: 3,834 citations2022: 1,851 citations2023: 968 citations2024: 1,262 citations2025: 471 citations2026: 12 citations1975–1977: no citations, so these years are not shown1980–1981: no citations, so these years are not shown1983–1986: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,392 citing papers, 21.2% of this breakdownChina: 2,748 citing papers, 17.2% of this breakdownIndia: 921 citing papers, 5.8% of this breakdownUnited Kingdom: 729 citing papers, 4.6% of this breakdownItaly: 561 citing papers, 3.5% of this breakdownGermany: 509 citing papers, 3.2% of this breakdownCanada: 428 citing papers, 2.7% of this breakdownIran: 396 citing papers, 2.5% of this breakdownFrance: 361 citing papers, 2.2% of this breakdownAustralia: 337 citing papers, 2.1% of this breakdownSouth Korea: 295 citing papers, 1.8% of this breakdownSaudi Arabia: 289 citing papers, 1.8% of this breakdown
0%21.2%Other 31.4%

Institutions

Fields

  • Medicine70.3%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Immunology and Microbiology7.2%
  • Computer Science2.9%
  • Agricultural and Biological Sciences2.6%
  • Engineering1.1%
  • Other5.1%

Topics

  • SARS-CoV-2 and COVID-19 Research19.2%
  • COVID-19 Clinical Research Studies11.7%
  • Animal Virus Infections Studies3.8%
  • SARS-CoV-2 detection and testing3.4%
  • Long-Term Effects of COVID-193.4%
  • Viral gastroenteritis research and epidemiology3.1%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

    Authors: Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang - Nature reviews. Immunology 2022 cited by 404

  2. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

    Authors: Shuai Xia, Meiqin Liu, Chao Wang, Wei Xu, Qiaoshuai Lan, Siliang Feng, Feifei Qi, Linlin Bao, Lanying Du, Shuwen Liu, Chuan Qin, Fei Sun, Zhengli Shi, Yun Zhu, Shibo Jiang, Lu Lu - Cell Research 2020 cited by 1,438

  3. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

    Authors: Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou, Lanying Du - Cellular and Molecular Immunology 2020 cited by 1,814

  4. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

    Authors: Shuai Wang, Zongyang Qiu, Yingnan Hou, Xiya Deng, Wei Xu, Tingting Zheng, Peihan Wu, Shaofang Xie, Weixiang Bian, Chong Zhang, Zewei Sun, Kunpeng Liu, Chao Shan, Aifu Lin, Shibo Jiang, Youhua Xie, Qiang Zhou, Lu Lu, Jing Huang, Xu Li - Cell Research 2021 cited by 511

  5. The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    Authors: Lanying Du, Yuxian He, Yusen Zhou, Shuwen Liu, Bo-Jian Zheng, Shibo Jiang - Nature Reviews Microbiology 2009 cited by 1,772

  6. Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody

    Authors: Cheng Li, Wuqiang Zhan, Zhenlin Yang, Chao Tu, Gaowei Hu, Xiang Zhang, Wenping Song, Shujuan Du, Yuanfei Zhu, Keke Huang, Yu Kong, Meng Zhang, Qiyu Mao, Xiaodan Gu, Yi Zhang, Youhua Xie, Qiang Deng, Yuanlin Song, Zhenguo Chen, Lu Lu, Shibo Jiang, Yanling Wu, Lei Sun, Tianlei Ying - Cell 2022 cited by 189

  7. Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity

    Authors: Ji Wang, Peiyu Li, Yang Yu, YuHong Fu, Hongye Jiang, Min Lu, Zhiping Sun, Shibo Jiang, Lu Lu, Mei X. Wu - Science 2020 cited by 307

  8. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

    Authors: Hongjing Gu, Qi Chen, Guan Yang, Lei He, Hang Fan, Yong‐Qiang Deng, Yanxiao Wang, Yue Teng, Zhongpeng Zhao, Yujun Cui, Yuchang Li, Xiao-Feng Li, Jiangfan Li, Na-Na Zhang, Xiaolan Yang, Shaolong Chen, Yan Guo, Guangyu Zhao, Xiliang Wang, Deyan Luo, Hui Wang, Xiao Yang, Yan Li, Gencheng Han, Yuxian He, Xiaojun Zhou, Shusheng Geng, Xiaoli Sheng, Shibo Jiang, Shihui Sun, Cheng‐Feng Qin, Yusen Zhou - Science 2020 cited by 848

  9. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

    Authors: Qianqian Zhang, Rong Xiang, Shanshan Huo, Yunjiao Zhou, Shibo Jiang, Qiao Wang, Fei Yu - Signal Transduction and Targeted Therapy 2021 cited by 353

  10. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

    Authors: Shuai Xia, Yun Zhu, Meiqin Liu, Qiaoshuai Lan, Wei Xu, Yanling Wu, Tianlei Ying, Shuwen Liu, Zhengli Shi, Shibo Jiang, Lu Lu - Cellular and Molecular Immunology 2020 cited by 758

  11. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines

    Authors: Lang Rao, Shuai Xia, Wei Xu, Rui Tian, Guocan Yu, Chenjian Gu, Pan Pan, Qian-Fang Meng, Xia Cai, Di Qu, Lu Lu, Youhua Xie, Shibo Jiang, Xiaoyuan Chen - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 258

  12. Antivirals with common targets against highly pathogenic viruses

    Authors: Lu Lu, Shan Su, Haitao Yang, Shibo Jiang - Cell 2021 cited by 165

  13. Recent advances in the detection of respiratory virus infection in humans

    Authors: Naru Zhang, Lili Wang, Xiaoqian Deng, Ruiying Liang, Meng Su, Chen He, Lanfang Hu, Yudan Su, Jing Ren, Fei Yu, Lanying Du, Shibo Jiang - Journal of Medical Virology 2020 cited by 572

  14. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations

    Authors: Yi Yang, Weilai Sun, Jingjing Guo, Guangyu Zhao, Shihui Sun, Hong Yu, Yan Guo, Jungfeng Li, Xia Jin, Lanying Du, Shibo Jiang, Zhihua Kou, Yusen Zhou - Human Vaccines & Immunotherapeutics 2015 cited by 153

  15. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants

    Authors: Cun Li, Jingjing Huang, Yifei Yu, Zhixin Wan, Man Chun Chiu, Xiaojuan Liu, Shuxin Zhang, Jian‐Piao Cai, Hin Chu, Gang Li, Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To, Zifeng Yang, Shibo Jiang, Kwok‐Yung Yuen, Hans Clevers, Jie Zhou - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 69

  16. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    Authors: Shuai Xia, Lei Yan, Wei Xu, Anurodh Shankar Agrawal, Abdullah Algaissi, Chien‐Te K. Tseng, Qian Wang, Lanying Du, Wenjie Tan, Ian A. Wilson, Shibo Jiang, Bei Yang, Lu Lu - Science Advances 2019 cited by 529

  17. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

    Authors: Yang Yang, Lanying Du, Chang Liu, Lili Wang, Cuiqing Ma, Jian Tang, Ralph S. Baric, Shibo Jiang, Fang Li - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 299

  18. Receptor Usage and Cell Entry of Porcine Epidemic Diarrhea Coronavirus

    Authors: Chang Liu, Jian Tang, Yuanmei Ma, Xueya Liang, Yang Yang, Guiqing Peng, Qianqian Qi, Shibo Jiang, Jiànróng Lǐ, Lanying Du, Fang Li - Journal of Virology 2015 cited by 271

  19. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences

    Authors: Xinling Wang, Lu Lu, Shibo Jiang - Trends in Immunology 2024 cited by 52

  20. Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines

    Authors: Pan Huang, Lujia Sun, Jinhao Li, Qingyi Wu, Nima Rezaei, Shibo Jiang, Chungen Pan - Cell Discovery 2023 cited by 70

  21. A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant

    Authors: Man Chun Chiu, Cun Li, Xiaojuan Liu, Yifei Yu, Jingjing Huang, Zhixin Wan, Ding Xiao, Hin Chu, Jian‐Piao Cai, Biao Zhou, Ko‐Yung Sit, Wing‐Kuk Au, Kenneth Kak‐Yuen Wong, Gang Li, Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To, Zhiwei Chen, Shibo Jiang, Hans Clevers, Kwok‐Yung Yuen, Jie Zhou - Cell Discovery 2022 cited by 80

  22. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry

    Authors: Wenjiao Wu, Richan Li, Xianglian Li, Jian He, Shibo Jiang, Shuwen Liu, Jie Yang - Viruses 2015 cited by 429

  23. Identification of Human Single-Domain Antibodies against SARS-CoV-2

    Authors: Yanling Wu, Cheng Li, Shuai Xia, Xiaolong Tian, Yu Kong, Zhi Wang, Chenjian Gu, Rong Zhang, Chao Tu, Youhua Xie, Zhenlin Yang, Lu Lu, Shibo Jiang, Tianlei Ying - Cell Host & Microbe 2020 cited by 281

  24. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein

    Authors: Wei Pang, Ying Lu, Yan‐Bo Zhao, Fan Shen, Changfa Fan, Qian Wang, Wen-Qiang He, Xiao-Yan He, Zekai Li, Taotao Chen, Cuixian Yang, You-Zhi Li, Si-Xuan Xiao, Zu-Jiang Zhao, Xusheng Huang, Rong‐Hua Luo, Liu‐Meng Yang, Mi Zhang, Xingqi Dong, Minghua Li, Xiaoli Feng, Qing-Cui Zhou, Wang Qu, Shibo Jiang, Songying Ouyang, Yong‐Tang Zheng - Cell Research 2022 cited by 79